Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCT + Anti-CD19 CAR T cells in B-cell lymphoma
NCT05755828Phase 2Unknown
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Dec 2022
- Primary completion
- Dec 2024
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of mivocabtagene autoleucel in B-cell non-Hodgkin lymphoma, sponsored by The Affiliated Hospital of Xuzhou Medical University. Status: unknown.
02
Drugs
mivocabtagene autoleucel
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT05755828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05755828.